Investigation Of The Effects Of Polymicrobial Infection On The Induction Of Otitis Media
Funder
National Health and Medical Research Council
Funding Amount
$235,511.00
Summary
Middle ear infection is a highly prevalent paediatric disease characterised by an inflammation of the middle ear and is the most prevalent illness of childhood. It is reported that greater than 80% of children have had at least one episode of acute otitis media by 3 years of age and almost 40% of children have more than 6 episodes by age 7 years. The cause and pathogenesis of middle ear infection are multifactorial and influence of prevalence and chonicity of the infections. Prevention of bacter ....Middle ear infection is a highly prevalent paediatric disease characterised by an inflammation of the middle ear and is the most prevalent illness of childhood. It is reported that greater than 80% of children have had at least one episode of acute otitis media by 3 years of age and almost 40% of children have more than 6 episodes by age 7 years. The cause and pathogenesis of middle ear infection are multifactorial and influence of prevalence and chonicity of the infections. Prevention of bacterial middle ear infection caused by Streptococcus pneumoniae, nontypeable Haemophilus influenzae and Moraxella catarrhalis requires a much better knowledge of how these bacteria interact with each other and with the host. The poor efficacy of the current pneumococcal paediatric vaccine for preventing middle ear infections highlights this deficiency in our knowledge and will impede the development of a suitable multvalent vaccine to prevent infection by the 3 major bacterial pathogens. This study will investigate how the bacteria colonising the respiratory tract interact during infection and how they affect the host.Read moreRead less
The Darwin Prospective Melioidosis Study: Years 27-31
Funder
National Health and Medical Research Council
Funding Amount
$1,281,718.00
Summary
The Darwin Prospective Melioidosis Study has documented 914 cases since 1989, with 115 fatalities. A surge in Darwin melioidosis cases over the past 5 years has been linked to urban development and the discovery of a new bacterial strain. Whole genome sequencing of our unique 25+ year set of bacteria and their linked patient data will unravel the changing epidemiology and identify important virulence factors, forming a foundation for future diagnostics, therapeutics, and vaccines.
Bacteriology Of Bronchiectasis In Australian Indigenous Children
Funder
National Health and Medical Research Council
Funding Amount
$91,209.00
Summary
Many Indigenous children in the Northern Territory suffer from a chronic lung condition called bronchiectasis. This disease causes a lot of illness and can lead to early death in adulthood. Little is known about how the disease starts and how it can be prevented, but many children are being treated with the antibiotic azithromycin. My project aims to find out which bacteria are associated with bronchiectasis, how azithromycin affects the bacteria, and whether it leads to antibiotic resistance.
Identification Of Proteins Specific To Transmissible Pseudomonas Aeruginosa In Cystic Fibrosis Infection
Funder
National Health and Medical Research Council
Funding Amount
$443,007.00
Summary
Cystic fibrosis (CF) is the most common autosomal recessive disorder in humans, affecting 1:2000 people. Mortality is often caused by Pseudomonas aeruginosa lung infections which have recently been shown to occur not only environmentally but also via person-person contact, usually during CF clinic visits. This project will elucidate the molecular traits responsible for these 'epidemic' P. aeruginosa infections, with the aim of finding novel therapeutics and infection control strategies.
Killing Infected Cells As A Mechanism To Eradicate Tuberculosis
Funder
National Health and Medical Research Council
Funding Amount
$1,085,770.00
Summary
Mycobacterium tuberculosis (Mtb), the causative agent of TB, is rapidly becoming resistant to all antibiotics and this disease kills more than one million people each year. This underscores the urgent need to develop new treatments for this disease. We are developing a therapy that kills Mtb infected cells and may help to eradicate infection. This highly novel approach to the treatment of TB would have profound implications for the 2 billion people infected with this pathogen.
Metabolism-driven Interactions Of Non-typeable Haemophilus Influenzae And Its Host: A Critical Factor In Infection?
Funder
National Health and Medical Research Council
Funding Amount
$474,932.00
Summary
Non-typeable Haemophilus influenzae (NTHi) is the underlying cause of many severe acute and chronic respiratory infections, which represent a significant burden to the healthcare system. As NTHi is unable to survive outside the human host, it is is highly adapted to survival in the body niches it colonizes. We are investigating how NTHI is able to survive in the presence of tissue inflammation, and whether it contributes to the inflammatory process through some of its metabolic products.
Long-term Macrolide Therapy; Oropharyngeal Dysbiosis And The Spread Of Resistant Pathogens
Funder
National Health and Medical Research Council
Funding Amount
$384,153.00
Summary
Use of macrolide therapy for chronic lung diseases is increasing rapidly. We will determine the impact of long-term macrolide antibiotic use on upper airway bacteria in patients with lung disease, and assess its contribution to antibiotic resistance in the wider community. We will investigate the mechanism by which this therapy achieves benefit and assess interference with bacterial signalling as a means to improve treatment efficacy and reduce induction of antibiotic resistance.
The Pathogenesis Of Melioidosis: The Interaction Of Burkholderia Pseudomallei With Host Cells.
Funder
National Health and Medical Research Council
Funding Amount
$344,375.00
Summary
Melioidosis is an often fatal disease of mainly tropical Australia and SE Asia caused by a bacterium which is found in soil and water. Infection occurs via wounds or by inhalation. Melioidosis has recently become endemic in south-west Western Australia and south-eastern Queensland, and could represent an emerging disease worldwide. Melioidosis disproportionately affects Aboriginal Australians. Melioidosis has many forms including septicemia with damage to most organs, particularly lung, spleen a ....Melioidosis is an often fatal disease of mainly tropical Australia and SE Asia caused by a bacterium which is found in soil and water. Infection occurs via wounds or by inhalation. Melioidosis has recently become endemic in south-west Western Australia and south-eastern Queensland, and could represent an emerging disease worldwide. Melioidosis disproportionately affects Aboriginal Australians. Melioidosis has many forms including septicemia with damage to most organs, particularly lung, spleen and liver, acute localised suppurative infection and pneumonia. Melioidosis may also become latent, and later develop into an acute and fatal infection. It is important to understand, at the molecular level, how and why the causative bacterium is able to cause disease. Only with such an understanding can measures be undertaken to prevent the disease, or novel methods developed to control the disease. Colonisation of a host is a first step in the disease process for all bacteria which cause disease. Large protein molecules located on the surface of disease-causing bacteria are usually neccessary for colonisation of the host since they allow adherence to the surface of host cells. We have previously undertaken a basic study of adherence. This study will build on this research with the aim of identifying molecules which mediate adherence to host cells, using in vivo and in vitro methods, including the techniques of molecular biology. This study will inevitably lead to the development of vaccine candidates which is important to the management of melioidosis, particularly in high risk groups. It may also allow the development of novel antimicrobial compounds.Read moreRead less
Dissecting Immune Responses To Salmonella Infection
Funder
National Health and Medical Research Council
Funding Amount
$415,797.00
Summary
Successful treatment of Salmonella infections requires a detailed understanding how Salmonella growth is controlled. This project will examine the role of white blood cells, will reveal how they contribute to the control of Salmonella infections and will test novel treatment options. The outcome of this project will significantly advance our understanding of immune responses against Salmonella.
Understanding The Role Of The Two Major Bacterial Pathogens In The Upper And Lower Airways Of Indigenous Children With Chronic Lung Disease
Funder
National Health and Medical Research Council
Funding Amount
$743,282.00
Summary
Lung infections are a major disease burden worldwide. Indigenous Australians are affected more; adults with severe lung disease can die in their 30s and 40s. These diseases start early, yet no in-depth studies of bacteria causing lung infections in children have been done. Our expert team proposes to use existing lung fluids from nearly 500 children with chronic lung disease (58% Indigenous), and state-of-the-art laboratory methods, to inform the design of vaccines to prevent lung disease.